- Home
- MNPR vs MMD Comparison
MNPR vs MMD Comparison
Compare MNPR & MMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- MMD
- Stock Information
- Founded
- MNPR 2014
- MMD 2012
- Country
- MNPR United States
- MMD United States
- Employees
- MNPR N/A
- MMD N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- MMD Investment Managers
- Sector
- MNPR Health Care
- MMD Finance
- Exchange
- MNPR Nasdaq
- MMD Nasdaq
- Market Cap
- MNPR 248.8M
- MMD 276.1M
- IPO Year
- MNPR 2019
- MMD N/A
- Fundamental
- Price
- MNPR $35.71
- MMD $14.71
- Analyst Decision
- MNPR Strong Buy
- MMD
- Analyst Count
- MNPR 7
- MMD 0
- Target Price
- MNPR $62.00
- MMD N/A
- AVG Volume (30 Days)
- MNPR 20.7K
- MMD 74.7K
- Earning Date
- MNPR 08-12-2025
- MMD 01-01-0001
- Dividend Yield
- MNPR N/A
- MMD 4.88%
- EPS Growth
- MNPR N/A
- MMD N/A
- EPS
- MNPR N/A
- MMD N/A
- Revenue
- MNPR N/A
- MMD N/A
- Revenue This Year
- MNPR N/A
- MMD N/A
- Revenue Next Year
- MNPR N/A
- MMD N/A
- P/E Ratio
- MNPR N/A
- MMD N/A
- Revenue Growth
- MNPR N/A
- MMD N/A
- 52 Week Low
- MNPR $2.15
- MMD $14.30
- 52 Week High
- MNPR $54.30
- MMD $17.67
- Technical
- Relative Strength Index (RSI)
- MNPR 43.81
- MMD 52.35
- Support Level
- MNPR $30.51
- MMD $14.60
- Resistance Level
- MNPR $36.51
- MMD $15.60
- Average True Range (ATR)
- MNPR 3.33
- MMD 0.23
- MACD
- MNPR -0.95
- MMD 0.01
- Stochastic Oscillator
- MNPR 37.55
- MMD 23.93
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About MMD MainStay MacKay DefinedTerm Municipal Opportunities Fund
NYLI MacKay DefinedTerm Muni Opportunities Fund is a USA-based diversified closed-end management investment company. The fund's investment objective is to seek current income exempt from regular U.S. Federal income taxes as well as total return. The company predominantly invests in municipal bonds, the interest on which is, in the opinion of bond counsel to the issuers, generally excludable from gross income for regular U.S. Federal income tax purposes.